Description
### SEMAGLUTIDE MED (semaglutide) for Injection
**HIGHLIGHTS OF PRESCRIBING INFORMATION**
These highlights do not include all the information needed to use SEMAGLUTIDE MED safely and effectively. See full prescribing information for SEMAGLUTIDE MED.
SEMAGLUTIDE MED injection, for subcutaneous use
**INDICATIONS AND USAGE**
SEMAGLUTIDE MED is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for investigational use in promoting weight loss, appetite suppression, and metabolic health in bodybuilding settings. Not approved for all indications in many jurisdictions; consult local regulations (1).
**DOSAGE AND ADMINISTRATION**
– Administer subcutaneously using a prefilled dosing pen.
– Adults (males and females): 0.25 mg to 2.4 mg per week, titrated gradually (2.1).
– Cycle duration: As needed for weight management, typically 12-16 weeks.
**DOSAGE FORMS AND STRENGTHS**
Solution: Variable dosing pen (0.25 mg to 2.4 mg) (3).
**CONTRAINDICATIONS**
– Hypersensitivity to semaglutide or any component of the formulation (4).
– Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (4).
– Pregnancy (4).
**WARNINGS AND PRECAUTIONS**
– Gastrointestinal effects: May cause nausea or diarrhea; monitor patient comfort (5.1).
– Hypoglycemia: Risk with concurrent insulin use; monitor glucose (5.2).
– Thyroid tumors: Monitor for thyroid abnormalities (5.3).
– Pancreatitis: Discontinue if suspected (5.4).
**ADVERSE REACTIONS**
Common adverse reactions include nausea, diarrhea, and injection site reactions (6).
**DRUG INTERACTIONS**
– Insulin or oral hypoglycemics: May enhance effects; monitor glucose (7.1).
– Oral medications: May delay absorption; adjust timing (7.2).
**USE IN SPECIFIC POPULATIONS**
– Pregnancy: Contraindicated (8.1).
– Lactation: Not recommended (8.2).
– Pediatric use: Safety not established (8.4).
– Geriatric use: Monitor for organ dysfunction (8.5).
Revised: 08/2025
**FULL PRESCRIBING INFORMATION**
**1 INDICATIONS AND USAGE**
SEMAGLUTIDE MED is indicated for investigational use in adults to promote significant weight loss, suppress appetite, improve insulin sensitivity, enhance cardiovascula
